Malcolm Lyon

6.1k total citations
69 papers, 5.2k citations indexed

About

Malcolm Lyon is a scholar working on Cell Biology, Molecular Biology and Hepatology. According to data from OpenAlex, Malcolm Lyon has authored 69 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cell Biology, 54 papers in Molecular Biology and 16 papers in Hepatology. Recurrent topics in Malcolm Lyon's work include Proteoglycans and glycosaminoglycans research (56 papers), Glycosylation and Glycoproteins Research (35 papers) and Liver physiology and pathology (16 papers). Malcolm Lyon is often cited by papers focused on Proteoglycans and glycosaminoglycans research (56 papers), Glycosylation and Glycoproteins Research (35 papers) and Liver physiology and pathology (16 papers). Malcolm Lyon collaborates with scholars based in United Kingdom, United States and France. Malcolm Lyon's co-authors include John T. Gallagher, Jon A. Deakin, J. T. Gallagher, William P. Steward, Maryse Delehedde, David G. Fernig, Graham Rushton, Dušan Uhrı́n, Jeremy E. Turnbull and J T Gallagher and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Malcolm Lyon

69 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm Lyon United Kingdom 42 3.0k 2.9k 889 619 509 69 5.2k
Neta Ilan Israel 53 5.8k 1.9× 6.0k 2.0× 553 0.6× 609 1.0× 180 0.4× 156 8.4k
Dorothe Spillmann Sweden 44 2.8k 0.9× 2.5k 0.9× 685 0.8× 235 0.4× 86 0.2× 73 4.9k
Paraskevi Heldin Sweden 40 2.8k 0.9× 2.9k 1.0× 261 0.3× 287 0.5× 131 0.3× 88 4.6k
Charles B. Underhill United States 27 2.9k 0.9× 2.9k 1.0× 506 0.6× 352 0.6× 69 0.1× 44 5.1k
Björn Öbrink Sweden 42 2.4k 0.8× 1.1k 0.4× 497 0.6× 566 0.9× 352 0.7× 99 5.0k
Ralph D. Sanderson United States 64 7.2k 2.4× 6.0k 2.0× 1.1k 1.2× 500 0.8× 246 0.5× 128 11.1k
John Hilkens Netherlands 40 4.6k 1.5× 670 0.2× 2.3k 2.6× 619 1.0× 99 0.2× 92 6.3k
Espen Stang Norway 37 3.8k 1.3× 2.7k 0.9× 841 0.9× 325 0.5× 93 0.2× 80 5.8k
Robert G. Oshima United States 51 4.4k 1.5× 2.7k 0.9× 762 0.9× 410 0.7× 121 0.2× 119 7.5k
Robert Hyman United States 46 4.3k 1.4× 2.8k 1.0× 2.9k 3.3× 237 0.4× 48 0.1× 103 7.8k

Countries citing papers authored by Malcolm Lyon

Since Specialization
Citations

This map shows the geographic impact of Malcolm Lyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Lyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Lyon more than expected).

Fields of papers citing papers by Malcolm Lyon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm Lyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Lyon. The network helps show where Malcolm Lyon may publish in the future.

Co-authorship network of co-authors of Malcolm Lyon

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm Lyon. A scholar is included among the top collaborators of Malcolm Lyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm Lyon. Malcolm Lyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deakin, Jon A., et al.. (2011). Preparation of heparin/heparan sulfate oligosaccharides with internal N-unsubstituted glucosamine residues for functional studies. Glycoconjugate Journal. 28(8-9). 525–535. 11 indexed citations
2.
Tátrai, Péter, Áron Somorácz, Toin H. Van Kuppevelt, et al.. (2010). Quantitative and Qualitative Alterations of Heparan Sulfate in Fibrogenic Liver Diseases and Hepatocellular Cancer. Journal of Histochemistry & Cytochemistry. 58(5). 429–441. 64 indexed citations
3.
Schmidt, Christoph Q., Andrew P. Herbert, David Kavanagh, et al.. (2008). A New Map of Glycosaminoglycan and C3b Binding Sites on Factor H. The Journal of Immunology. 181(4). 2610–2619. 172 indexed citations
4.
Holmes, Oliver, Serena Pillozzi, Jon A. Deakin, et al.. (2007). Insights into the Structure/Function of Hepatocyte Growth Factor/Scatter Factor from Studies with Individual Domains. Journal of Molecular Biology. 367(2). 395–408. 79 indexed citations
5.
Raiber, Eun‐Ang, James A. Wilkinson, Fabrizio Manetti, et al.. (2007). Novel heparin/heparan sulfate mimics as inhibitors of HGF/SF-induced MET activation. Bioorganic & Medicinal Chemistry Letters. 17(22). 6321–6325. 14 indexed citations
6.
Herbert, Andrew P., Dušan Uhrı́n, Malcolm Lyon, Michael K. Pangburn, & Paul N. Barlow. (2006). Disease-associated Sequence Variations Congregate in a Polyanion Recognition Patch on Human Factor H Revealed in Three-dimensional Structure. Journal of Biological Chemistry. 281(24). 16512–16520. 80 indexed citations
7.
Lyon, Malcolm, Jon A. Deakin, Daniel Lietha, Ermanno Gherardi, & John T. Gallagher. (2004). The Interactions of Hepatocyte Growth Factor/Scatter Factor and Its NK1 and NK2 Variants with Glycosaminoglycans Using a Modified Gel Mobility Shift Assay. Journal of Biological Chemistry. 279(42). 43560–43567. 49 indexed citations
8.
Lyon, Malcolm. (2003). The Isolation of Membrane Proteoglycans. Humana Press eBooks. 19. 243–252. 1 indexed citations
9.
Lyon, Malcolm, Jon A. Deakin, & John T. Gallagher. (2002). The Mode of Action of Heparan and Dermatan Sulfates in the Regulation of Hepatocyte Growth Factor/Scatter Factor. Journal of Biological Chemistry. 277(2). 1040–1046. 64 indexed citations
10.
Delehedde, Maryse, Rishma Vidyasagar, David G. Fernig, Malcolm Lyon, & Timothy J. McDonnell. (2002). Hepatocyte Growth Factor/Scatter Factor Binds to Small Heparin-derived Oligosaccharides and Stimulates the Proliferation of Human HaCaT Keratinocytes. Journal of Biological Chemistry. 277(14). 12456–12462. 45 indexed citations
11.
Delehedde, Maryse, Nicolas Sergeant, Malcolm Lyon, Philip S. Rudland, & David G. Fernig. (2001). Hepatocyte growth factor/scatter factor stimulates migration of rat mammary fibroblasts through both mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase/Akt pathways. European Journal of Biochemistry. 268(16). 4423–4429. 45 indexed citations
12.
Delehedde, Maryse, Malcolm Lyon, Nicolas Sergeant, Hassan Rahmoune, & David G. Fernig. (2001). Proteoglycans: Pericellular and Cell Surface Multireceptors that Integrate External Stimuli in the Mammary Gland. Journal of Mammary Gland Biology and Neoplasia. 6(3). 253–273. 57 indexed citations
13.
Béchard, David, Thibaut Gentina, Maryse Delehedde, et al.. (2001). Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic Activity. Journal of Biological Chemistry. 276(51). 48341–48349. 196 indexed citations
14.
Lyon, Malcolm, Graham Rushton, Janet A. Askari, Martin J. Humphries, & John T. Gallagher. (2000). Elucidation of the Structural Features of Heparan Sulfate Important for Interaction with the Hep-2 Domain of Fibronectin. Journal of Biological Chemistry. 275(7). 4599–4606. 75 indexed citations
15.
Jayson, Gordon C., et al.. (1998). Heparan Sulfate Undergoes Specific Structural Changes during the Progression from Human Colon Adenoma to Carcinoma in Vitro. Journal of Biological Chemistry. 273(1). 51–57. 113 indexed citations
16.
Lyon, Malcolm & John T. Gallagher. (1994). Hepatocyte growth factor/scatter factor: a heparan sulphate-binding pleiotropic growth factor. Biochemical Society Transactions. 22(2). 365–370. 30 indexed citations
17.
Gallagher, J. T., Jeremy E. Turnbull, & Malcolm Lyon. (1992). Heparan Sulphate Proteoglycans: Molecular Organisation of Membrane-Associated Species and an Approach to Polysaccharide Sequence Analysis. Advances in experimental medicine and biology. 313. 49–57. 16 indexed citations
18.
Nelson, Stephen, Malcolm Lyon, J. T. Gallagher, Edward A. Johnson, & Mark B. Pepys. (1991). Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid A and monoclonal light-chain amyloid fibrils. Biochemical Journal. 275(1). 67–73. 60 indexed citations
19.
Lyon, Malcolm, William P. Steward, Ian Hampson, & J T Gallagher. (1987). Identification of an extended N-acetylated sequence adjacent to the protein-linkage region of fibroblast heparan sulphate. Biochemical Journal. 242(2). 493–498. 39 indexed citations
20.
Gallagher, J. T., Malcolm Lyon, & William P. Steward. (1986). Structure and function of heparan sulphate proteoglycans. Biochemical Journal. 236(2). 313–325. 429 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026